Pharmacokinetics of tolbutamide after oral administration to rabbits with folate-lnduced renal failure

Archives of Pharmacal Research

Volumn 26, Issue 11, 2003, Pages 979-983

  Choi, Jun Shik ^a   Shin, Sang Chul ^b  

^a Chosun University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Oral admimstration; Pharmacokinetics; Renal failure; Tolbutamide

Indexed keywords

FOLIC ACID; TOLBUTAMIDE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; KIDNEY FAILURE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RABBIT;

ADMINISTRATION, ORAL; ANIMALS; FOLIC ACID; KIDNEY FAILURE; MALE; RABBITS; TOLBUTAMIDE;

EID: 3042681455     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/BF02980209     Document Type: Article

References (23)

1. Ayanoglu, G., A new aspect of serum protein binding of tolbutamide.Int. J. Clin. Pharmcol. Ther. Toxicol., 24(2), 65–68 (1986).
2. Adir, J., Effects of total plasma concentration and age on tolbutamide plasma protein binding.Clin. Pharmcol. Ther., 31(4), 488–493 (1982).
3. Balant, L. P., Dayer, P., and Faber, J., Consequences of renal insufficiency on the hepatic clearance of some drugs.Int. J. Clin. Pharmacol. Res., 3, 459–474 (1983).
4. Beck-Nielsen, H., Hjllund, E., and Sorensen, N. S., Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.Diabetes Care, 7(Suppl1), 100–105 (1984).
5. Belandger, P. M., The characteristics of the microsomal hydroxylation of tolbutamide.Can. J. Physiol. Pharmacol., 69(3), 400–405 (1991).
6. Bailey, C. J., Flatt, P. R. and Marks, V., Drugs inducing hypoglycaemia.Pharmac. Ther., 42, 361–382 (1982). DOI: 10.1016/0163-7258(89)90031-4
7. Dogterom, P., A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Quantative and quantitative sex differences.Drug Metab. Dispos., 21(4), 705–709 (1993).
8. Ferner, R. E. and Chaplin, S., The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycemic drugs.Clin. Pharmacokin., 12, 379–401 (1987). DOI: 10.2165/00003088-198712060-00001
9. Hosker, J. P., Brunett, M. A., and Turner R. C, Sulfonylurea therapy doubles beta-cell response to glucose in Type 2 diabetic patients.Diabetologia., 28, 809–814 (1985). DOI: 10.1007/BF00291069
10. Knodell, R. G., Hall, S. D., and Guengerich, F. P., Hepatic metabolism of tolbutamide.J. Pharmacol. Exp. Ther., 241, 1112–1119 (1987).
11. Melander, A., Clinical pharmacology of sulfonylureas.Metabolism, 36(Suppl 1), 12–16 (1987). DOI: 10.1016/0026-0495(87)90195-8
12. Melander, A., Sartor, G., and Bitzen, P. O., Serum tolbutamide and chlorpropamide concentrations in patients with diabete melllitus.Br. Med. J., 1, 142–144 (1978). DOI: 10.1136/bmj.1.6106.142
13. Miners, J. O., Smith, K. J., and Veronase M. E., Tolbutamide hydroxylation by human liver microsomes.Biochem. Pharmacol., 37, 1137–1144 (1988). DOI: 10.1016/0006-2952(88)90522-9
14. Page, M. A., Boutagy, J. S., and Shenfield, G. M., A screening test for slow metabolisers of tolbutamide.Br. J. Clin. Pharmacol., 31, 649–654 (1991).
15. Relling, M. V., Aoyma, T., and Meyer, U. A., Tolbutamide and mephenytoin hydroxylation by human cytochrome P-450 in the CY2C subfamilly.J. Pharmacol. Exp. Ther., 252, 442–447 (1990).
16. Srivastava, P. K., Separation of human liver microsomal tolbutamide hydroxylase and S-mephenytoin 4′-hydroxylase cytochrome p-450 enzymes.Mol. Pharmacol., 401, 69–79 (1991).
17. Sturgess, N. C., Ashord, M. I., and Cook, D. I., The sulfonylurea receptor may be an ATP-seneitive potassium channel.Lancet., 11, 474–475 (1985). DOI: 10.1016/S0140-6736(85)90403-9
18. Schary, W. L. and Rowland, M., Protein binding and hepatic clearance. J. Pharmacokin. Biopharm., 11, 225–43 (1983). DOI: 10.1007/BF01061866
19. Terao, N. and Shen, D. D., Effect of experimental renal failure on the disposition kinetics of L-propranolol in rats.J. Pharmacol. Exp. Ther., 227, 295–301 (1983).
20. Veronese, M. E., McManus, M. E., and Birkett, D. J., Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.Drug. Metab. Dispos., 18, 356–361 (1990).
21. Ward, E. A., Ward, G. M., and Turner, R. C., Effect of sulfonylurea therapy on insulin secretion and glucose control of insulin-treated diabetics.Br. Med. J., 283, 278–280 (1981).
22. Yamao, Y., Nakagami, H., and Furuhama, K., Pharmacokinetics of tolbutamide following intravenous and oral administrations in rats with obstructive jaundice.Biol. Pharm. Bull., 17, 691–695 (1994).
23. Yamaoka, K., Tanigawara, Y., Nakagawa, T., and, Uno, T., A pharmacokinetics analysis program for microcomputer.J. Pharm. Dym., 4, 879–883 (1981).